Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2022)10.1016/j.bbadis.2022.166414Source: DataRank Database

FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis is a research paper published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (28)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Oscar Chen ORCID,John Pierce Wise ORCID,Hongxue Shi ORCID,Kupper A. Wintergerst,Lu Cai ORCID

Live enrichment

PubMed:35447340 PMC:PMC9617478

American Diabetes Association

Grant: 1-13-JF-53

National Institutes of Health

Grant: R01HL125877

National Institutes of Health

Grant: R01HL160927

National Institutes of Health

Grant: 5R01HL125877-05

A novel mechanism of stromal cell-derived factor 1 protection against diabetic cardiomyopathy

National Institutes of Health

Grant: 5R01HL160927-03

Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9617478

publisherhttps://api.elsevier.com/content/article/PII:S0925443922000849?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0925443922000849?httpAccept=text/plain

https://doi.org/10.1016/j.bbadis.2022.166414

https://pubmed.ncbi.nlm.nih.gov/35447340

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansMiceDiabetic NephropathiesDiabetes Mellitus, Type 2Disease Models, AnimalFibrosisInflammationFibroblast Growth Factor 1PPAR alphaApoptosis

Keywords

ApoptosisInflammationDiabetic nephropathyType 2 diabetesfibrosisFgf1(δhbs)Disease Models, AnimalMiceDiabetes Mellitus, Type 2AnimalsFibroblast Growth Factor 1HumansDiabetic NephropathiesPPAR alpha

Sustainable Development Goals

SDG 3: 3. Good health